Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q1

4885.TEDINET S100PCWF
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.5bn2022-06-01 → 2022-08-31StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥1.3bn2021-06-01 → 2021-08-31StandaloneNet sales
Operating income¥130m2022-06-01 → 2022-08-31StandaloneOperating income
Operating income¥169m2021-06-01 → 2021-08-31StandaloneOperating income
Ordinary income¥118m2022-06-01 → 2022-08-31StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥170m2021-06-01 → 2021-08-31StandaloneOrdinary income
Profit before tax¥118m2022-06-01 → 2022-08-31StandaloneIncome before income taxes
Profit before tax¥170m2021-06-01 → 2021-08-31StandaloneIncome before income taxes
Net income¥86m2022-06-01 → 2022-08-31StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥122m2021-06-01 → 2021-08-31StandaloneProfit loss
Total assets¥4.8bnat 2022-08-31StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.5bnat 2021-08-31StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2022-08-31StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2022-08-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.4bnat 2021-08-31StandaloneNet assets (5-year summary)
Cash and deposits¥683mat 2022-08-31StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
EPS (basic)¥23.132022-06-01 → 2022-08-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.372021-06-01 → 2021-08-31StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥22.752022-06-01 → 2022-08-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥30.092021-06-01 → 2021-08-31StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio35.7%at 2022-08-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio31.0%at 2021-08-31StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2022-08-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-08-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥508m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥508m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-08-31¥26m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥241m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥241m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-08-31−¥711,000
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥778m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥778m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-08-31¥105m
—segment totalrevenue2022-06-01 → 2022-08-31¥1.5bn
—segment totalrevenue external2022-06-01 → 2022-08-31¥1.5bn
—segment totalsegment profit2022-06-01 → 2022-08-31¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-08-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-08-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-08-31¥130m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥469m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥469m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥19m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥301m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥301m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥40m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥558m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥558m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥111m
—segment totalrevenue2021-06-01 → 2021-08-31¥1.3bn
—segment totalrevenue external2021-06-01 → 2021-08-31¥1.3bn
—segment totalsegment profit2021-06-01 → 2021-08-31¥169m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-08-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-08-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-08-31¥169m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 363
ItemContextValueUnit
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember11273000JPY
Other noePrior1YTDDuration_NonConsolidatedMember253000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember328000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember4602000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember15637000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember170404000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember118448000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember7000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember7000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember－JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember170397000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember118448000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember479000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember3922000JPY
Income taxes deferredPrior1YTDDuration_NonConsolidatedMember47605000JPY
Income taxes deferredCurrentYTDDuration_NonConsolidatedMember28170000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember48085000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember32093000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember122312000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember86354000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000PharmaceuticalBusinessReportableSegmentMember557892000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000HealthyFoodBusinessReportableSegmentMember301427000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000ChemicalProductsBusinessReportableSegmentMember468924000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember1328244000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember1328244000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember1328244000JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000PharmaceuticalBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000HealthyFoodBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000ChemicalProductsBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000PharmaceuticalBusinessReportableSegmentMember557892000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000HealthyFoodBusinessReportableSegmentMember301427000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000ChemicalProductsBusinessReportableSegmentMember468924000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember1328244000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember1328244000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember1328244000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000PharmaceuticalBusinessReportableSegmentMember110527000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000HealthyFoodBusinessReportableSegmentMember39563000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000ChemicalProductsBusinessReportableSegmentMember19247000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember169338000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember169338000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember169338000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E36350-000PharmaceuticalBusinessReportableSegmentMember777524000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2022-08-31pass
statement vs summary · revenuenon_consolidated 2021-06-01/2021-08-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-08-31pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2022-08-31pass